Boothbay Fund Management’s Agilon Health AGL Stock Holding History

Boothbay Fund Management’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$460K	Buy	+4,289	New	+$281K	0.01%	1550
2025 Q1	–	Sell	-1,230	Closed	-$58.4K	–	1372
2024 Q4	$58.4K	Buy	+1,230	New	+$74.4K	﹤0.01%	1339
2024 Q3	–	Sell	-1,985	Closed	-$325K	–	1583
2024 Q2	$325K	Buy	+1,985	New	+$283K	0.01%	1134
2023 Q3	–	Sell	-473	Closed	-$205K	–	1692
2023 Q2	$205K	Buy	+473	New	+$266K	﹤0.01%	1482
2022 Q4	–	Sell	-496	Closed	-$291K	–	1966
2022 Q3	$291K	Buy	+496	New	+$297K	0.01%	1557
2021 Q4	–	Sell	-2,838	Closed	-$1.86M	–	1825
2021 Q3	$1.86M	Buy	+2,838	New	+$2.42M	0.05%	477

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NPCM

North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Boothbay Fund Management's AGL Position: Q2 2026 in Review

Boothbay Fund Management opened a new position in Agilon Health (AGL) in Q2 2026: 4,289 shares worth $460K. The stake represents 0.01% of the portfolio and ranks #1550 among its holdings. This is a return to the name: Boothbay Fund Management previously reported a position in AGL as recently as Q4 2024.

Boothbay Fund Management first reported a position in AGL in Q3 2021 and has held it in 6 quarters since. The position peaked at $1.86M in Q3 2021. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

Boothbay Fund Management held 4,289 shares of Agilon Health worth $460K as of Q2 2026.
Agilon Health was a new Boothbay Fund Management position in Q2 2026.
Agilon Health made up 0.01% of Boothbay Fund Management's portfolio in Q2 2026, its #1550 holding.
Boothbay Fund Management first reported a position in Agilon Health in Q3 2021 and has held it in 6 quarters since.
Boothbay Fund Management's Agilon Health position peaked at $1.86M in Q3 2021.
179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.